Using the cut-off values of above 10% and 50%, the percentage of cases with EGFR positive tumours were 30% and 4%, HER-2 positive tumours were12% and 8% and HER-3 positive tumours were 45% and 22%, respectively (Table 2). The gene discussed is ERBB2; the disease is neoplasm.